WeChat Mini Program
Old Version Features

B-cell Tailored Dosing Versus Standard Interval Dosing of Ocrelizumab in Relapsing-Onset MS -Interim Analysis of a Randomized Controlled Trial (BLOOMS Trial)

MULTIPLE SCLEROSIS JOURNAL(2024)

Cited 0|Views4
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined